AKT1 and prostate cancer: LncRNA SNHG7 was also suggested to promote EMT in prostate cancer via binding to miRNA-324-3p, as well as through the Wnt pathway [212], while the lncRNA E3 ubiquitin-protein ligase (CHFR) was found to act through multiple pathways via miR-10b to promote EMT in PC3 cells, mainly through the GSK/AKT and NF-κB pathways [213].